{"nct_id":"NCT06122649","title":"A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2023-11-27","start_date_type":"ACTUAL","primary_completion_date":"2025-02-28","primary_completion_date_type":"ACTUAL","completion_date":"2025-12-07","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AMGN"]}